protein 1,274 words KG: VCP 2026-03-20
kind:proteinsection:proteinsstate:published
Contents

VCP Protein

🔬 Protein Info
Gene SymbolVCP
Chromosome9p13.3
Protein FamilyAAA+ ATPase family
Protein TypeEnzyme
Target ClassEnzyme
FunctionSmall molecule inhibitors of VCP ATPase activity affecting protein quality control
Mechanism of ActionSmall molecule inhibitors of VCP ATPase activity affecting protein quality control
Primary ExpressionUbiquitous - Brain, Muscle, Spinal cord
Subcellular LocalizationCytoplasm, nucleus, ER, mitochondria
DruggabilityMedium (0.50)
Clinical StagePhase I
Molecular Weight97 kDa
Amino Acids806 aa
Exons17
PathwaysAkt, Autophagy, Er Stress, Mitophagy, Ubiquitin-Proteasome
UniProt IDP55072
Ensembl IDENSG00000165280
GeneCardsVCP
Human Protein AtlasVCP
Associated DiseasesALS, AMI, AUTOPHAGY, Alzheimer, Alzheimer's Disease
Known Drugs/CompoundsRAPAMYCIN, rapamycin
InteractionsTBK1, CHMP2B, OVERVIEW, VALOSIN, JUN, RANK
SciDEX TargetView Target Profile (4 clinical trials)
SciDEX HypothesesVCP-Mediated Autophagy Enhancement
KG Connections915 knowledge graph edges
DatabasesGeneCardsNCBI GeneHPASTRING

Knowledge Graph

Related Hypotheses (20)

VCP-Mediated Autophagy Enhancement
Score: 0.41
Phase-Separated Organelle Targeting
Score: 0.52
Heat Shock Protein 70 Disaggregase Amplification
Score: 0.51
Stress Granule Phase Separation Modulators
Score: 0.49
RNA Granule Nucleation Site Modulation
Score: 0.48

Related Analyses (8)

Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived

Related Experiments (5)

Autophagy Enhancement Drug Screening for Neurodegeneration
clinical · proposed · Score: 0.40
Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40
Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic
validation · proposed · Score: 0.40
Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
clinical · proposed · Score: 0.40
Proteasome-Ubiquitin System Dysfunction Validation in Parkin
clinical · proposed · Score: 0.40

See Also (5)

Aging vs Neurodegeneration: Mechanistic Comparison Matr
mechanism · KG edge: expressed_in
Actin Cytoskeleton Dynamics in Neurodegeneration
mechanism · KG edge: co_discussed
Packard Center for ALS Research
institution · KG edge: activates
AMPK (AMP-Activated Protein Kinase)
entity · KG edge: associated_with
Amyotrophic Lateral Sclerosis
redirect · KG edge: activates

Knowledge Graph (12 edges)

VCP regulates VCP-Mediated Autophagy Enhancement
VCP regulates Tau Propagation
VCP activates TBK1
VCP activates CHMP2B
VCP activates OVERVIEW
VCP activates VALOSIN
VCP associated_with SQSTM1
VCP associated_with TIA1
VCP associated_with HNRNPA2B1
VCP associated_with HNRNPA1